Closed Patch Test (24 hrs)to assess dermatological safety of test products.
- Registration Number
- CTRI/2013/03/003474
- Lead Sponsor
- ITC R D Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 24
Subject age group 18-55 years.
-Healthy Male and Female Volunteers.
-Subject with skin type III and IV.
-Subject willing to give a written Informed consent.
-Subject willing to maintain the patch test in position for 24 hrs.
-Subject has not participated in similar investigation in the past two weeks.
-Subject willing to come for regular follow up.
-Subject ready to follow instructions during the study period.
-Infection, Allergy on tested area.
-Skin allergy antecedents or atopic subjects.
-Hyper sensitivity to any component of the tested products.
-Athletes and subjects with history of excessive sweating.
-Cutaneous disease which may influence the study result.
-Chronic illness which may influence the cutaneous state.
- Subjects on oral corticosteroid with dose 10mg/day.
-Subjects participating in any other cosmetic or therapeutic trial.
-Any history of underlying uncontrolled medical illness including diabetes, Liver disease or history of alcoholism, HIV or any other serious medical illness.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To evaluate the dermatological safety of the given investigational product/s on skin of healthy human volunteers by primary irritation patch test.Timepoint: 9 Days for each subject.
- Secondary Outcome Measures
Name Time Method ILTimepoint: NI
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.